ResearcherCentre Hospitalier Universitaire de LiègeActive in the last 2 years

Gilles Colin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9580-0793; OpenAlex author ID A5039657325. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

Challenges and opportunities in combining radiotherapy and immunotherapy for localized pancreatic cancer. Co-author DOI 10.1038/s41575-026-01250-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Éric Deutsch · 1 shared paper, 2026 · strength 0.39
- Paper Challenges and opportunities in combining radiotherapy and immunotherapy for localized pancreatic cancer. DOI 10.1038/s41575-026-01250-4 ↗
Lorenzo Galluzzi · 1 shared paper, 2026 · strength 0.39
- Paper Challenges and opportunities in combining radiotherapy and immunotherapy for localized pancreatic cancer. DOI 10.1038/s41575-026-01250-4 ↗
Pierre Foidart · 1 shared paper, 2026 · strength 0.39
- Paper Challenges and opportunities in combining radiotherapy and immunotherapy for localized pancreatic cancer. DOI 10.1038/s41575-026-01250-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.